Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Bill Wexler's Profits of DOOM -- Ignore unavailable to you. Want to Upgrade?

To: mesaone who wrote (2705)	9/14/1998 9:07:00 AM
From: Spunky Beaver	Read Replies (3) \| Respond to of 4634

Have you checked with anyone in the medical community about the viability of Hextend? The surgeons I have worked with scoff at the product and laughed at it's rumored selling price. What good is FDA approval if no one is going to buy it? I'm neither short or long on this dog and have never had a position in it, however I have followed it for the past 2 years out of curiosity. This dog has already had it's day. I suggest you move on and buy some gold bars or something, at least it will be worth something in the future. If you think FDA approval is going to breathe value into this worthless company, go buy yourself some CCSI, they are near their 52 week low and their product already has FDA approval. SB